ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 102627 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 102627; 2) Community: the network communities that were significantly associated with the response to NSC 102627; 3) Molecule: the relationships between components within communities and NSC 102627; 4) MDR: the compounds that were significantly associated with the NSC 102627.

NSC Compound Enrichment Correlation
NSC 13151 Null 0.049093561024907 0.18605578
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.049093561024907 0.35738886
NSC 173552 L-Aspartic acid, N-[4-[[(2-amino-4-hydroxy-6-quinazolinyl)methyl]amino]benzoyl]-, monohydrate 0.049093561024907 0.4444374
NSC 22709 v-Triazolo[4,5-d]pyrimidin-7-ol 0.049093561024907 0.36071407
NSC 23925 Null 0.049093561024907 0.25193783
NSC 258168 2,6-Pyridinedicarbonitrile, 3,4,5-tris(phenylthio)- 0.049093561024907 0.13377971
NSC 263434 N,N'-Bis(3-methoxy-9-acridinyl)-1,8-octanediamine 0.049093561024907 0.25468365
NSC 300289 Pinafide 0.049093561024907 0.64800203
NSC 303812 Aphidicoline glycinate 0.049093561024907 0.80682612
NSC 303861 L-Cysteine analog 0.049093561024907 0.43041939
Total:122  Current:115    [First] [Prev] [Next] [Last]